THAP3
gene geneOn this page
Summary
THAP3 (THAP domain containing 3, HGNC:20855) is a protein-coding gene on chromosome 1p36.31, encoding THAP domain-containing protein 3 (Q8WTV1). Component of a THAP1/THAP3-HCFC1-OGT complex that is required for the regulation of the transcriptional activity of RRM1.
Predicted to enable DNA binding activity and zinc ion binding activity. Involved in positive regulation of transcription by RNA polymerase II.
Source: NCBI Gene 90326 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 42 total
- MANE Select transcript:
NM_001195753
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20855 |
| Approved symbol | THAP3 |
| Name | THAP domain containing 3 |
| Location | 1p36.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000041988 |
| Ensembl biotype | protein_coding |
| OMIM | 612532 |
| Entrez | 90326 |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 12 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron, 1 nonsense_mediated_decay
ENST00000054650, ENST00000307896, ENST00000377627, ENST00000472925, ENST00000480647, ENST00000484669, ENST00000484676, ENST00000487819, ENST00000866303, ENST00000866304, ENST00000866305, ENST00000866306, ENST00000922198, ENST00000922199, ENST00000922200, ENST00000953195
RefSeq mRNA: 8 — MANE Select: NM_001195753
NM_001195752, NM_001195753, NM_001394496, NM_001394497, NM_001394498, NM_001394499, NM_001394500, NM_138350
CCDS: CCDS55572, CCDS55573, CCDS86
Canonical transcript exons
ENST00000054650 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001402591 | 6625150 | 6625292 |
| ENSE00001474647 | 6624868 | 6624954 |
| ENSE00002956509 | 6632796 | 6633562 |
| ENSE00003406981 | 6628499 | 6628691 |
| ENSE00003477092 | 6630288 | 6630353 |
| ENSE00003674101 | 6632391 | 6632495 |
Expression profiles
Bgee: expression breadth ubiquitous, 175 present calls, max score 91.59.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.8813 / max 93.0240, expressed in 1784 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 413 | 6.9615 | 1766 |
| 412 | 0.9197 | 310 |
Top tissues by expression
286 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| apex of heart | UBERON:0002098 | 91.59 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 89.97 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 88.16 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 87.97 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 87.94 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.89 | gold quality |
| cerebellar cortex | UBERON:0002129 | 87.80 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 87.70 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 87.50 | gold quality |
| endocervix | UBERON:0000458 | 87.49 | gold quality |
| lower esophagus | UBERON:0013473 | 87.49 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 87.44 | gold quality |
| cortical plate | UBERON:0005343 | 87.34 | gold quality |
| granulocyte | CL:0000094 | 87.19 | gold quality |
| right adrenal gland | UBERON:0001233 | 87.17 | gold quality |
| popliteal artery | UBERON:0002250 | 87.14 | gold quality |
| tibial artery | UBERON:0007610 | 87.13 | gold quality |
| frontal pole | UBERON:0002795 | 87.08 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 87.07 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 87.01 | gold quality |
| body of uterus | UBERON:0009853 | 86.92 | gold quality |
| aorta | UBERON:0000947 | 86.72 | gold quality |
| right coronary artery | UBERON:0001625 | 86.62 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 86.61 | gold quality |
| gastrocnemius | UBERON:0001388 | 86.61 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 86.59 | gold quality |
| ascending aorta | UBERON:0001496 | 86.45 | gold quality |
| thoracic aorta | UBERON:0001515 | 86.44 | gold quality |
| right frontal lobe | UBERON:0002810 | 86.33 | gold quality |
| left adrenal gland | UBERON:0001234 | 86.32 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-110499 | no | 36.17 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
26 targeting THAP3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-3667-3P | 99.99 | 67.17 | 1636 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-3140-3P | 99.88 | 68.47 | 2069 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
| HSA-MIR-17-3P | 99.55 | 66.77 | 1311 |
| HSA-MIR-136-5P | 99.50 | 67.26 | 1153 |
| HSA-MIR-6727-3P | 99.49 | 65.92 | 1333 |
| HSA-MIR-6081 | 99.48 | 66.07 | 1446 |
| HSA-MIR-12132 | 99.47 | 68.90 | 1341 |
| HSA-MIR-6083 | 99.47 | 68.73 | 2393 |
| HSA-MIR-4251 | 99.40 | 69.19 | 3363 |
| HSA-MIR-4722-3P | 99.35 | 65.22 | 1099 |
| HSA-MIR-7515 | 99.31 | 68.22 | 1795 |
| HSA-MIR-6814-5P | 99.03 | 66.68 | 1273 |
| HSA-MIR-6512-5P | 98.76 | 69.29 | 1195 |
| HSA-MIR-6516-5P | 98.42 | 70.19 | 1551 |
| HSA-MIR-6780A-3P | 98.42 | 67.49 | 1518 |
| HSA-MIR-1263 | 98.13 | 69.18 | 459 |
| HSA-MIR-3665 | 97.73 | 65.08 | 975 |
| HSA-MIR-6511A-3P | 97.60 | 66.61 | 713 |
| HSA-MIR-6511B-3P | 97.60 | 66.61 | 713 |
| HSA-MIR-3200-5P | 97.34 | 65.97 | 826 |
| HSA-MIR-6854-3P | 90.99 | 65.18 | 155 |
Literature-anchored findings (GeneRIF, showing 1)
- THAP3 recruits SMYD3 to OXPHOS genes and epigenetically promotes mitochondrial respiration in hepatocellular carcinoma. (PMID:38664231)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:ch211-69l10.4 | ENSDARG00000098036 |
| danio_rerio | si:dkey-50i6.5 | ENSDARG00000101320 |
| mus_musculus | Thap3 | ENSMUSG00000039759 |
| rattus_norvegicus | Thap3 | ENSRNOG00000026840 |
| drosophila_melanogaster | CG13894 | FBGN0035157 |
Paralogs (7): THAP1 (ENSG00000131931), ARL14EP (ENSG00000152219), THAP8 (ENSG00000161277), THAP2 (ENSG00000173451), THAP6 (ENSG00000174796), THAP7 (ENSG00000184436), ARL14EPL (ENSG00000268223)
Protein
Protein identifiers
THAP domain-containing protein 3 — Q8WTV1 (reviewed: Q8WTV1)
All UniProt accessions (3): Q8WTV1, K7EIZ2, R4GNH0
UniProt curated annotations — full annotation on UniProt →
Function. Component of a THAP1/THAP3-HCFC1-OGT complex that is required for the regulation of the transcriptional activity of RRM1.
Subunit / interactions. Component of a THAP1/THAP3-HCFC1-OGT complex that contains at least, either THAP1 or THAP3, HCFC1 and OGT. Interacts directly with OGT and HCFC1 (via its HBM).
Tissue specificity. Highly expressed in heart, skeletal muscle and placenta. Weaker expression in brain, kidney and liver.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8WTV1-1 | 1 | yes |
| Q8WTV1-3 | 2 | |
| Q8WTV1-4 | 3 |
RefSeq proteins (8): NP_001182681, NP_001182682, NP_001381425, NP_001381426, NP_001381427, NP_001381428, NP_001381429, NP_612359 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006612 | THAP_Znf | Domain |
| IPR026520 | THAP3 | Family |
Pfam: PF05485
UniProt features (13 total): splice variant 4, mutagenesis site 3, chain 1, zinc finger region 1, sequence conflict 1, region of interest 1, short sequence motif 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WTV1-F1 | 71.57 | 0.37 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 122
Mutagenesis-validated functional residues (3):
| Position | Phenotype |
|---|---|
| 178 | abolishes interaction with hcfc1. |
| 180 | abolishes interaction with hcfc1. |
| 177–180 | abolishes interaction with hcfc1. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 50 (showing top):
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN, GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_DN, chr1p36, GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D, ALK_DN.V1_UP, PRKDC_TARGET_GENES, SETD7_TARGET_GENES, UBN1_TARGET_GENES, ZNF423_TARGET_GENES, ZNF711_TARGET_GENES, ZNF843_TARGET_GENES, ZSCAN30_TARGET_GENES
GO Biological Process (1): positive regulation of transcription by RNA polymerase II (GO:0045944)
GO Molecular Function (4): DNA binding (GO:0003677), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of transcription by RNA polymerase II | 1 |
| transcription by RNA polymerase II | 1 |
| positive regulation of DNA-templated transcription | 1 |
| nucleic acid binding | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
370 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| THAP3 | THAP12 | O43422 | 882 |
| THAP3 | THAP11 | Q96EK4 | 877 |
| THAP3 | DNAJC11 | Q9NVH1 | 625 |
| THAP3 | THAP6 | Q8TBB0 | 621 |
| THAP3 | THAP4 | Q8WY91 | 574 |
| THAP3 | THAP10 | Q9P2Z0 | 570 |
| THAP3 | RRM1 | P23921 | 537 |
| THAP3 | THAP8 | Q8NA92 | 490 |
| THAP3 | PAWR | Q96IZ0 | 469 |
| THAP3 | OGT | O15294 | 459 |
| THAP3 | KLHL21 | Q9UJP4 | 424 |
| THAP3 | HCFC1 | P51610 | 405 |
| THAP3 | TNFRSF25 | P78507 | 385 |
| THAP3 | ZNF251 | Q9BRH9 | 373 |
| THAP3 | SZRD1 | Q7Z422 | 370 |
IntAct
81 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GTF2H4 | GTF2H1 | psi-mi:“MI:0914”(association) | 0.670 |
| THAP3 | GTF2H4 | psi-mi:“MI:0915”(physical association) | 0.620 |
| NUTF2 | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| THAP3 | UBL5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CHAT | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FGFR3 | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GRIN2C | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LSAMP | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NDUFS1 | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| POLR2A | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PKN1 | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RAC1 | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SNRPB | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TYR | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UQCRB | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UQCRC1 | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| VBP1 | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EZR | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| DNALI1 | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BAG6 | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KLF11 | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DNAJB6 | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UBQLN1 | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TARDBP | THAP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (85): THAP3 (Affinity Capture-MS), THAP3 (Reconstituted Complex), THAP3 (Two-hybrid), THAP3 (Affinity Capture-MS), THAP3 (Affinity Capture-RNA), THAP3 (Negative Genetic), THAP3 (Negative Genetic), THAP3 (Negative Genetic), THAP3 (Negative Genetic), THAP3 (Positive Genetic), THAP3 (Positive Genetic), THAP3 (Positive Genetic), NUTF2 (Two-hybrid), UBL5 (Two-hybrid), THAP3 (Two-hybrid)
ESM2 similar proteins: A2AGX3, A4Q9F3, A6QPH9, D3YYI7, E9PGG2, P29590, Q0P5B4, Q0VC73, Q2TBI2, Q3T0G1, Q45KJ4, Q45KJ6, Q4R7H0, Q5BJT4, Q5E9N3, Q5NVM3, Q5PPH4, Q5U208, Q5XI57, Q642B6, Q6P3Z3, Q6P9L4, Q6ZN17, Q6ZVT0, Q70EL4, Q7L4P6, Q8AVK2, Q8BJ25, Q8BUM9, Q8C6D4, Q8CDF7, Q8CE64, Q8CHW1, Q8N554, Q8NA92, Q8NFT6, Q8TC41, Q8VCZ3, Q8WTV1, Q8WY91
Diamond homologs: B5XCB8, Q0IHI7, Q0P5B4, Q1JPT7, Q1RMM0, Q2TBI2, Q3T0G1, Q4R3Q6, Q4R7M0, Q5RCE4, Q5U208, Q5U560, Q5ZHN5, Q642B6, Q6DDT6, Q6DIN8, Q6P3Z3, Q7Z6K1, Q8BJ25, Q8CHW1, Q8WTV1, Q8WY91, Q9D305, Q9H0W7, Q9NVV9, Q8NA92, Q9H5L6, Q8VCZ3, Q9BT49, Q8TBB0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
42 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 30 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
988 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:6625272:G:GT | donor_gain | 1.0000 |
| 1:6625290:CCG:C | donor_gain | 1.0000 |
| 1:6625292:GGT:G | donor_loss | 1.0000 |
| 1:6625293:G:GG | donor_gain | 1.0000 |
| 1:6625293:GT:G | donor_loss | 1.0000 |
| 1:6628494:CTTA:C | acceptor_loss | 1.0000 |
| 1:6628495:TTA:T | acceptor_loss | 1.0000 |
| 1:6628496:TA:T | acceptor_loss | 1.0000 |
| 1:6628497:A:AG | acceptor_gain | 1.0000 |
| 1:6628498:G:GG | acceptor_gain | 1.0000 |
| 1:6628689:CAGGT:C | donor_loss | 1.0000 |
| 1:6625288:CACCG:C | donor_gain | 0.9900 |
| 1:6625289:ACCG:A | donor_gain | 0.9900 |
| 1:6625291:CG:C | donor_gain | 0.9900 |
| 1:6625292:GG:G | donor_gain | 0.9900 |
| 1:6628494:CTTAG:C | acceptor_gain | 0.9900 |
| 1:6628495:TTAGG:T | acceptor_gain | 0.9900 |
| 1:6628496:TAG:T | acceptor_gain | 0.9900 |
| 1:6628497:AG:A | acceptor_gain | 0.9900 |
| 1:6628497:AGGTT:A | acceptor_gain | 0.9900 |
| 1:6628498:G:T | acceptor_gain | 0.9900 |
| 1:6628498:GG:G | acceptor_gain | 0.9900 |
| 1:6628498:GGT:G | acceptor_gain | 0.9900 |
| 1:6628498:GGTT:G | acceptor_gain | 0.9900 |
| 1:6628498:GGTTT:G | acceptor_gain | 0.9900 |
| 1:6630286:A:AG | acceptor_gain | 0.9900 |
| 1:6630287:G:GG | acceptor_gain | 0.9900 |
| 1:6633002:G:GT | donor_gain | 0.9900 |
| 1:6628490:T:TA | acceptor_gain | 0.9800 |
| 1:6628493:CCTTA:C | acceptor_gain | 0.9800 |
AlphaMissense
1571 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:6625285:T:C | F23L | 1.000 |
| 1:6625287:C:A | F23L | 1.000 |
| 1:6625287:C:G | F23L | 1.000 |
| 1:6628533:T:A | W37R | 1.000 |
| 1:6628533:T:C | W37R | 1.000 |
| 1:6628535:G:C | W37C | 1.000 |
| 1:6628535:G:T | W37C | 1.000 |
| 1:6628599:T:C | F59L | 1.000 |
| 1:6628600:T:C | F59S | 1.000 |
| 1:6628601:C:A | F59L | 1.000 |
| 1:6628601:C:G | F59L | 1.000 |
| 1:6625231:T:C | C5R | 0.999 |
| 1:6625288:C:G | H24D | 0.999 |
| 1:6628501:T:C | F26S | 0.999 |
| 1:6628585:T:A | I54N | 0.999 |
| 1:6628587:T:A | C55S | 0.999 |
| 1:6628587:T:C | C55R | 0.999 |
| 1:6628588:G:A | C55Y | 0.999 |
| 1:6628588:G:C | C55S | 0.999 |
| 1:6628589:C:G | C55W | 0.999 |
| 1:6628600:T:G | F59C | 0.999 |
| 1:6628659:C:A | P79T | 0.999 |
| 1:6628659:C:T | P79S | 0.999 |
| 1:6628660:C:A | P79H | 0.999 |
| 1:6628668:T:C | F82L | 0.999 |
| 1:6628670:C:A | F82L | 0.999 |
| 1:6628670:C:G | F82L | 0.999 |
| 1:6625286:T:C | F23S | 0.998 |
| 1:6625288:C:A | H24N | 0.998 |
| 1:6628500:T:C | F26L | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000102480 (1:6628854 C>A), RS1000160269 (1:6634153 G>A,C), RS1000165263 (1:6624830 C>A), RS1000851247 (1:6633613 A>C), RS1001039185 (1:6624080 A>C,G), RS1001167064 (1:6625734 G>T), RS1001263963 (1:6634912 G>A), RS1001906718 (1:6634369 T>C), RS1002438719 (1:6630093 A>G), RS1002448009 (1:6629634 CT>C), RS1003159593 (1:6631926 T>C), RS1003440822 (1:6631092 C>A,T), RS1003507983 (1:6626993 G>A), RS1003641621 (1:6626409 C>G,T), RS1004005229 (1:6631078 C>T)
Disease associations
OMIM: gene MIM:612532 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010988_520 | Adult body size | 3.000000e-08 |
| GCST011769_1 | Schizophrenia | 8.000000e-09 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| bisphenol A | affects cotreatment, increases expression | 1 |
| beta-lapachone | increases expression | 1 |
| sodium arsenite | affects splicing, increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| abrine | increases expression | 1 |
| bisphenol S | affects cotreatment, increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Caffeine | decreases phosphorylation | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A7L4 | SEES3-1V human THAP3, clone1 | Embryonic stem cell | Male |
| CVCL_A7L5 | SEES3-1V human THAP3, clone2 | Embryonic stem cell | Male |
| CVCL_A7L6 | SEES3-1V human THAP3, clone3 | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.